Kidney Aging Impairs Progenitor and Endocrine Function
Kidney Aging Impairs Progenitor and Endocrine Function
批准号:
10341118
负责人:
Stuart James Shankland
金额:
$61.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-02-11 至 2023-12-31
关键词:
AdultAgeAgingAntibodiesAntioxidantsApoptosisAttentionBiogenesisBiologyCDKN2A geneCell CycleCell physiologyCellsChronicComplementCountryCultured CellsDNA DamageDataDialysis procedureDiseaseDisease OutcomeElderlyEnalaprilEndocrineEpithelial CellsErythrocytesEventExperimental ModelsFRAP1 geneFemaleFocal Segmental GlomerulosclerosisGenesGoalsGrantImpairmentIn VitroInflammationInflammatoryInjuryInjury to KidneyKidneyKidney DiseasesKnowledgeLabelLeadLosartanLoxP-flanked alleleMessenger RNAMitochondriaMusNatural regenerationParietalPericytesPhenotypePlasmaPopulationProcessProductionProteinsPublishingRNAReactive Oxygen SpeciesRenal glomerular diseaseReninReporterReportingRoleStimulusTestingTimeTransgenic Miceage relatedagedaging populationcell agecell regenerationclinically relevantcomplement systemcytokinedensitydesignhealthy agingimprovedin vivoinnovationkidney cellmalemesangial cellnephrogenesisolder patientpatient populationpodocytepreventprogenitorrecruitrepairedresponsesenescencestem cell functionstem cellstranscriptometranscriptome sequencingtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary and Abstract
Because the US population is living longer, the impact of advanced age on the kidney is highly clinically
relevant. Kidney disease outcomes are worse in the older versus younger patient population s and the elderly
comprise the largest group to initiate dialysis annually in the US. Recent attention in the aged kidney has been
given to cells of renin lineage because of their two essential functions: their endocrine function of producing the
body's supply of renin, and their adult progenitor function as facultative stem cells that transdifferentiate into
cell fates that they partially or fully replace, including podocytes. The scope of the problem is that in addition to
a decrease in total CoRL density in the aged kidney, both functions are also impaired with advancing age.
From the standpoint of glomerular diseases typified by podocyte depletion, reduced CoRL progenitor function
limits podocyte regeneration, and therefore repair in the aged kidney. We reported that aged CoRL undergo
senescence, apoptosis, and DNA damage, with an increase in complement components and inflammatory
cytokines, consistent with a chronic low-grade inflammatory state. Aged CoRL mitochondria have lower
biogenesis and energy, but increased reactive oxygen species accumulation. The knowledge gap is identifying
the mechanisms that cause these changes to CoRL in aged kidneys. Importantly, our data shows that
superimposed glomerular disease compounds the aging phenotype as follows: when podocytes are depleted
in young mice in experimental FSGS, the changes to the transcriptome in young CoRL are very similar to the
changes in CoRL in the healthy aged kidney without disease. We propose that changes to CoRL in glomerular
disease recapitulates and superimposes changes to CoRL in aged kidneys, and that this compounding effect
worsens disease outcomes in aged populations. The unmet need is targeting the mechanisms that impair
CoRL function in the aged kidney with disease, with the ultimate goal to minimize further injury to the aged
kidney. To achieve this, the following specific aims are proposed: (1) Test the hypothesis that senescence
impairs the facultative stem cell function of cells of renin lineage (CoRL) during aging. (2) Test the hypothesis
that chronic inflammation reduces the endocrine phenotype and function of aged cells of renin lineage. (3) Test
the hypothesis that mitochondrial changes in the aged kidney lowers the number of cells of renin lineage.
The significance of these studies includes uncovering, for the first time, potential mechanisms whereby age
impairs the CoRL endocrine phenotype and function, reduces CoRL progenitor function and lowers CoRL
density. In doing so, we will identify targets to modify in disease states in the aged kidney that maintain the
CoRL phenotype and enhance their functions. Innovations include identifying changes to a kidney cell (cells of
renin lineage) following injury to another kidney cell (podocyte loss) in FSGS that recapitulate the aged
phenotype, and that these superimposed changes are very detrimental to the aged kidney.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Intersection of Podocyte Disease and Aging
-
批准号:10733868
-
项目类别:
-
资助金额:$76.29万
-
财政年份:2023
-
负责人:Stuart James Shankland
-
依托单位:
Targeting Podocyte-Endothelial Cell Crosstalk as a FSGS Therapy
-
批准号:10635547
-
项目类别:
-
资助金额:$77.52万
-
财政年份:2023
-
负责人:Stuart James Shankland
-
依托单位:
Autocrine and paracrine podocyte signals decrease glomerular function/health in aged kidneys
-
批准号:10698100
-
项目类别:
-
资助金额:$73.57万
-
财政年份:2022
-
负责人:Stuart James Shankland
-
依托单位:
Kidney Aging Impairs Progenitor and Endocrine Function
-
批准号:10549835
-
项目类别:
-
资助金额:$60.87万
-
财政年份:2020
-
负责人:Stuart James Shankland
-
依托单位:
Cell specific delivery of novel therapies to enhance glomerular regeneration and repair
-
批准号:10675681
-
项目类别:
-
资助金额:$81.62万
-
财政年份:2020
-
负责人:Stuart James Shankland
-
依托单位:
Cell specific delivery of novel therapies to enhance glomerular regeneration and repair
-
批准号:10247521
-
项目类别:
-
资助金额:$81.62万
-
财政年份:2020
-
负责人:Stuart James Shankland
-
依托单位:
Cell specific delivery of novel therapies to enhance glomerular regeneration and repair
-
批准号:10414816
-
项目类别:
-
资助金额:$81.62万
-
财政年份:2020
-
负责人:Stuart James Shankland
-
依托单位:
Reduced Glomerular Progenitors Impair Regeneration in Aged Kidney
-
批准号:9329346
-
项目类别:
-
资助金额:$47.2万
-
财政年份:2016
-
负责人:Stuart James Shankland
-
依托单位:
Rebuilding the glomerular filtration barrier by regenerating adult podocytes
-
批准号:9564892
-
项目类别:
-
资助金额:$42.92万
-
财政年份:2015
-
负责人:Stuart James Shankland
-
依托单位:
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomerular disease
-
批准号:10436216
-
项目类别:
-
资助金额:$59.33万
-
财政年份:2014
-
负责人:Stuart James Shankland
-
依托单位:
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomerular disease
-
批准号:9816246
-
项目类别:
-
资助金额:$62.07万
-
财政年份:2014
-
负责人:Stuart James Shankland
-
依托单位:
Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomerular disease
-
批准号:10189566
-
项目类别:
-
资助金额:$59.67万
-
财政年份:2014
-
负责人:Stuart James Shankland
-
依托单位:
Pericyte-endothelial cross talk in vascular stability after kidney injury
-
批准号:8705506
-
项目类别:
-
资助金额:$49.92万
-
财政年份:2012
-
负责人:Stuart James Shankland
-
依托单位:
Pericyte-endothelial cross talk in vascular stability after kidney injury
-
批准号:8539599
-
项目类别:
-
资助金额:$49.34万
-
财政年份:2012
-
负责人:Stuart James Shankland
-
依托单位:
9th International Podocyte Conference
-
批准号:8317085
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2012
-
负责人:Stuart James Shankland
-
依托单位:
Pericyte-endothelial cross talk in vascular stability after kidney injury
-
批准号:8890141
-
项目类别:
-
资助金额:$49.67万
-
财政年份:2012
-
负责人:Stuart James Shankland
-
依托单位:
The role of Macrophage Delivered WNT Signaling in kidney injury and repair
-
批准号:8466959
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2009
-
负责人:Stuart James Shankland
-
依托单位:
Cell Cycle and Podocyte Apoptosis
-
批准号:7921100
-
项目类别:
-
资助金额:$8.58万
-
财政年份:2009
-
负责人:Stuart James Shankland
-
依托单位:
New Thoughts on Parietal Epithelial Cells
-
批准号:7739904
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2009
-
负责人:Stuart James Shankland
-
依托单位:
New Thoughts on Parietal Epithelial Cells
-
批准号:7912886
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2009
-
负责人:Stuart James Shankland
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: